medications | Horse Racing Free Tips

The Los Angeles Times Editorial Board acknowledged improved equine safety measures at Santa Anita Park over the past two years, reducing equine fatalities from 37 over the 2019 season to 16 over the same period in 2020. Still, the editorial board insists there are more steps to be taken to prevent further on-track fatalities across the entire state of California.

First, there should be public postings of all necropsy and fatality reviews on horses that die on California tracks.

“The horse racing board already posts annual overall reports on fatalities and types of injuries, but even more transparency is called for,” wrote the editorial board.

Another suggestion was a centralized pharmacy at the racetrack, which is the only source for medications.

Finally, while Santa Anita's PET scan has been a good investment, the editorial board believes the machine should be used on asymptomatic horses prior to a race. Additionally, a 3D walk-in CAT scanner could be added to track veterinarians' tool kit.

Read more at the Los Angeles Times.

The post Op/Ed: ‘Even More Transparency’ Needed At California Tracks appeared first on Horse Racing News | Paulick Report.

Source of original post

US racing commissions sent 263,783 biological samples from horses participating in professional horse races to the testing laboratories.

Of those tests there were 1,461 adverse analytical findings accounting for 0.55 percent of all samples. 99.45 percent of samples tested were clear, indicating a high degree of compliance with anti-doping and medication rules based upon known information and data..

Of the adverse analytical findings, approximately three percent were clear attempts at doping as the substance detected had no reason to be present in the horse other than to provide a maximum enhancement of performance. Class 2 substances considered the next most serious level of substances that can affect performance accounted for 6.09 percent of all findings. Class 1 and Class 2 substances are generally considered “doping” and together they account for 9.03 percent of all 2019 detections.

As in prior years, the overwhelming substance detections (69.75 percent) involved therapeutic medications (Class 4 and 5 substances) that may affect performance to a lesser extent, but are still not permitted to be present in a horse when it races. With the exception of race day furosemide to mitigate or prevent bleedings, horse racing does not permit use of these substances with a therapeutic use exemption as defined in the World Anti-Doping Code.

21.83 percent of the detections involved Class 3 substances. These have a greater ability to affect performance and contain substances which may be therapeutic as well as those that might indicate a deliberate attempt to cheat.

This information represents the official testing results from all horse racing US jurisdictions, except Maine which did not respond to repeated requests for information.

Like the testing results in human and Olympic sport, these numbers should not lessen the resolve of the sport and its regulators to pursue substances that the labs are unable to test for. This is an ongoing challenge for the anti-doping programs in all professional sport and underscores the need for intelligence based efforts in this regard as well as intelligence based out of competition testing.

The post National Summary: 0.55 Percent Of All Racing Samples Tested Show Adverse Analytical Findings appeared first on Horse Racing News | Paulick Report.

Source of original post